Thanks for the update. All of this early science is certainly confusing- [COO
CE Much the same thing that we are

hearing from Am College of Cardiology. | appreciate your keeping me informed.

 

How are you doing? [- G6)

Best,

From: Fauci, Anthony (NIH/NIAID) [E]

Sent: Friday, March 27, 2020 1:29 PM

0 ——SS=ZH>

Subject: [EXTERNAL] FW: medRxiv: Anti-hypertensive Angiotensin Il receptor blockers associated to
mitigation of disease severity in elderly COVID-19 patients

** ATTENTION: This email originated from outside the MedStar network.
** DO NOT CLICK links or attachments unless you recognize the sender and know the content ts safe.

See below. The situation continues to get more complicated.
Best,

Tony

Anthony S. Fauci, MD

Director

National Institute of Allergy and Infectious Diseases
Building 31, Room 7A-03

31 Center Drive, MSC 2520

National Institutes of Health

Bethesda, MD 20892-2520

Phone: ee
FAX: (301) 496-4409
E-mail: |
The information in this e-mail and any of its attachments is confidential and may contain sensitive
information. It should not be used by anyone who is not the original intended recipient. If you
have received this e-mail in error please inform the sender and delete it from your mailbox or any
other storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall not
accept liability for any statements made that are the sender's own and not expressly made on
behalf of the NIAID by one of its representatives.

Anti-hypertensive Angiotensin II receptor
blockers associated to mitigation of disease
severity in elderly COVID-19 patients

Yingxia Liu, Fengming Huang, Jun Xu, Penghui Yang, Yuhao Qin, Mengli Cao, Zhaoqin Wang, Xiaohe Li,
Shaogeng Zhang, Lu Ye, Jingjun Lv, Jie Wei, Tuxiu Xie, Hong Gao, Kai-Feng Xu, Fusheng Wang, Lei Liu,
Chengyu Jiang

 

NIH-000148
